US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Aardvark Therapeutics

6.82

+0.930015.79%

Post-market: 6.820.00000.00%19:30 EDT

Volume:173.69K

Turnover:1.12M

Market Cap:147.97M

PE:-2.13

High:6.90

Open:5.91

Low:5.80

Close:5.89

52wk High:17.94

52wk Low:3.35

Shares:21.70M

Float Shares:11.17M

Volume Ratio:1.18

T/O Rate:1.56%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.2080

EPS(LYR):-0.7400

ROE:-66.02%

ROA:-40.38%

PB:1.98

PE(LYR):-9.22

Loading ...

Overview Company News Filings

Aardvark Therapeutics Shares Fall 54% Premarket After Pausing Late-Stage Rare Disease Trial

THOMSON REUTERS

Stifel Nicolaus Downgrades Aardvark Therapeutics to Hold From Buy, Adjusts PT to $6 From $24

MT Newswires Live

Why Is Aardvark Therapeutics Stock Sinking Monday?

Aardvark Therapeutics Inc : Stifel Cuts to Hold From Buy; Cuts Target Price to $6 From $24

THOMSON REUTERS

RBC Downgrades Aardvark Therapeutics to Sector Perform From Outperform, Cuts Price Target to $6 From $18, Keeps Speculative Risk

MT Newswires Live

Aardvark Therapeutics Cut to Equal-Weight From Overweight by Morgan Stanley

Aardvark Therapeutics downgraded to Neutral from Buy at H.C. Wainwright

Aardvark Therapeutics, Inc. : H.c. Wainwright Cuts to Neutral From Buy

THOMSON REUTERS

Aardvark Therapeutics Cut to Sector Perform From Outperform by RBC Capital

Stock Market Today: S&P 500, Dow Jones Futures Slide Amid War Against Iran— AMTD Digital, Aardvark, MongoDB In Focus

Benzinga Earnings

Aardvark downgraded to Equal Weight from Overweight at Morgan Stanley

U.S. RESEARCH ROUNDUP-Aardvark Therapeutics, Chevron, CrowdStrike

Aardvark Therapeutics Inc : RBC Cuts to Sector Perform From Outperform; Cuts Target Price to $6 From $18

THOMSON REUTERS

Aardvark Therapeutics downgraded to Hold from Buy at Stifel

Stocks to Watch: Aardvark Therapeutics, Blue Moon Metals

Aardvark Therapeutics Pauses Trial After Finding Safety Issue

BUZZ-Aardvark Therapeutics falls after pausing late-stage rare disease trial

Aardvark Therapeutics down 54% to $5.70 after pausing Phase 3 HERO trial

Aardvark Therapeutics voluntarily pauses Phase 3 HERO trial

Aardvark Therapeutics pauses late-stage trial testing rare disease treatment

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/AARD/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AARD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AARD\",,,,,undefined,":{"symbol":"AARD","market":"US","secType":"STK","nameCN":"Aardvark Therapeutics","latestPrice":6.82,"timestamp":1787342400000,"preClose":5.89,"halted":0,"volume":173693,"hourTrading":{"tag":"盘后","latestPrice":6.82,"preClose":6.82,"latestTime":"19:30 EDT","volume":10,"amount":68.2,"timestamp":1787355006457,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.15789473684210537,"floatShares":11168300,"shares":21696893,"eps":-3.207951,"marketStatus":"Market Closed","change":0.93,"latestTime":"08-21 16:00:00 EDT","open":5.91,"high":6.9,"low":5.8,"amount":1117073.9794318,"amplitude":0.186757,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-3.207951,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1739509200000,"exchange":"NASDAQ","adjPreClose":5.89,"preHourTrading":{"tag":"盘前","latestPrice":6.0144,"preClose":5.89,"latestTime":"09:26 EDT","volume":211,"amount":1267.3644104,"timestamp":1787318775881,"change":0.1244,"changeRate":0.021121,"amplitude":0.036401},"postHourTrading":{"tag":"盘后","latestPrice":6.82,"preClose":6.82,"latestTime":"19:30 EDT","volume":10,"amount":68.2,"timestamp":1787355006457,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.1800854433265036,"impliedVol":0.9983,"impliedVolPercentile":0.3878},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AARD\",,,,,undefined,":{"symbol":"AARD","floatShares":11168300,"roa":"-40.38%","roe":"-66.02%","lyrEps":-0.74,"volumeRatio":1.1800854433265036,"shares":21696893,"dividePrice":0,"high":6.9,"amplitude":0.186757,"preClose":5.89,"low":5.8,"week52Low":3.35,"pbRate":"1.98","week52High":17.94,"institutionHeld":0,"latestPrice":6.82,"eps":-3.207951,"divideRate":0,"volume":173693,"delay":0,"ttmEps":-3.207951,"open":5.91,"prevYearClose":13.125,"prevWeekClose":6.54,"prevMonthClose":6.6,"prevQuarterClose":5.76,"fiveDayClose":6.54,"twentyDayClose":6.32,"sixtyDayClose":3.99},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AARD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"AARD","fiscalQuarterEnding":"2026/06","expectedEps":-0.87,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"post","actualEps":-0.66},{"market":"US","date":"2026-05-07","symbol":"AARD","fiscalQuarterEnding":"2026/03","expectedEps":-0.81,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":-0.99},{"market":"US","date":"2026-03-23","symbol":"AARD","fiscalQuarterEnding":"2025/12","expectedEps":-0.81,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774238400000,"reportTimeType":"post","actualEps":-0.81},{"market":"US","date":"2025-11-13","symbol":"AARD","fiscalQuarterEnding":"2025/09","expectedEps":-0.82,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.75},{"market":"US","date":"2025-08-13","symbol":"AARD","fiscalQuarterEnding":"2025/06","expectedEps":-0.52,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.66}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AARD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AARD\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AARD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AARD","date":"2026-08-21","current":-2.125968,"percent":0.843915,"low":-51.17654,"twenty":-9.46418,"median":-6.116088,"eighty":-2.0169,"high":-1.08662,"avg":-7.838471,"sd":8.376805,"marketCap":128901742},"quantilePoints":[{"date":"2025-02-21","current":-51.17654,"twenty":-46.993414,"median":-42.216938,"eighty":-39.920668,"marketCap":368880503},{"date":"2025-02-28","current":-39.75453,"twenty":-42.139802,"median":-40.229211,"eighty":-39.232381,"marketCap":286550651},{"date":"2025-03-07","current":-28.243517,"twenty":-40.603022,"median":-39.176012,"eighty":-36.900511,"marketCap":203579269},{"date":"2025-03-14","current":-31.091602,"twenty":-40.336014,"median":-37.766803,"eighty":-30.723725,"marketCap":224108270},{"date":"2025-03-21","current":-27.23482,"twenty":-39.944402,"median":-34.681377,"eighty":-29.198812,"marketCap":196308580},{"date":"2025-03-28","current":-26.404128,"twenty":-39.576524,"median":-30.913597,"eighty":-27.946841,"marketCap":190320955},{"date":"2025-04-04","current":-9.026143,"twenty":-39.119644,"median":-30.068072,"eighty":-27.341623,"marketCap":185830236},{"date":"2025-04-11","current":-7.397773,"twenty":-38.751766,"median":-29.400552,"eighty":-17.252871,"marketCap":152305358},{"date":"2025-04-17","current":-7.977371,"twenty":-38.300819,"median":-28.45119,"eighty":-8.603741,"marketCap":164238114},{"date":"2025-04-25","current":-8.66235,"twenty":-37.766803,"median":-27.946841,"eighty":-8.371497,"marketCap":178340462},{"date":"2025-05-02","current":-11.939711,"twenty":-36.900511,"median":-27.412825,"eighty":-8.371497,"marketCap":245814773},{"date":"2025-05-09","current":-11.307423,"twenty":-34.865316,"median":-26.68597,"eighty":-8.46634,"marketCap":232797221},{"date":"2025-05-16","current":-7.114571,"twenty":-32.693651,"median":-13.552046,"eighty":-8.46634,"marketCap":197215912},{"date":"2025-05-23","current":-7.834638,"twenty":-31.0204,"median":-11.823792,"eighty":-8.360959,"marketCap":217176159},{"date":"2025-05-30","current":-8.061615,"twenty":-30.818661,"median":-11.433881,"eighty":-8.172533,"marketCap":223467976},{"date":"2025-06-06","current":-9.353039,"twenty":-30.367714,"median":-11.107198,"eighty":-8.178795,"marketCap":259266244},{"date":"2025-06-13","current":-8.656453,"twenty":-30.076972,"median":-10.833207,"eighty":-8.210998,"marketCap":239956875},{"date":"2025-06-20","current":-9.454788,"twenty":-30.053238,"median":-10.188135,"eighty":-8.218152,"marketCap":262086713},{"date":"2025-06-27","current":-10.84796,"twenty":-29.697227,"median":-10.664596,"eighty":-8.356744,"marketCap":300705451},{"date":"2025-07-03","current":-10.894921,"twenty":-29.459887,"median":-10.613156,"eighty":-8.365174,"marketCap":302007206},{"date":"2025-07-11","current":-9.861782,"twenty":-29.308323,"median":-10.597502,"eighty":-8.375712,"marketCap":273368592},{"date":"2025-07-18","current":-9.360866,"twenty":-28.618005,"median":-10.433139,"eighty":-8.40036,"marketCap":259483203},{"date":"2025-07-25","current":-10.542714,"twenty":-28.285052,"median":-10.45662,"eighty":-8.474871,"marketCap":292244042},{"date":"2025-08-01","current":-9.4,"twenty":-28.006176,"median":-10.433139,"eighty":-8.577715,"marketCap":260567999},{"date":"2025-08-08","current":-9.368693,"twenty":-27.946841,"median":-10.061366,"eighty":-8.607418,"marketCap":259700162},{"date":"2025-08-15","current":-6.668132,"twenty":-27.567096,"median":-9.861782,"eighty":-8.474871,"marketCap":244307015},{"date":"2025-08-22","current":-5.762071,"twenty":-27.424692,"median":-9.803081,"eighty":-8.329026,"marketCap":211110768},{"date":"2025-08-29","current":-5.027748,"twenty":-27.270421,"median":-9.525229,"eighty":-8.145134,"marketCap":184206621},{"date":"2025-09-05","current":-5.027748,"twenty":-27.074615,"median":-9.478268,"eighty":-8.014507,"marketCap":184206621},{"date":"2025-09-12","current":-4.61321,"twenty":-26.629602,"median":-9.396086,"eighty":-7.797069,"marketCap":169018796},{"date":"2025-09-19","current":-6.685898,"twenty":-23.929853,"median":-9.368693,"eighty":-7.515801,"marketCap":244957921},{"date":"2025-09-26","current":-7.503129,"twenty":-17.043362,"median":-9.298251,"eighty":-7.308831,"marketCap":274899634},{"date":"2025-10-03","current":-9.102059,"twenty":-12.821851,"median":-9.210333,"eighty":-7.389343,"marketCap":333481245},{"date":"2025-10-10","current":-9.824539,"twenty":-12.161077,"median":-9.298251,"eighty":-7.460987,"marketCap":359951454},{"date":"2025-10-17","current":-7.876213,"twenty":-12.040618,"median":-9.212156,"eighty":-7.503145,"marketCap":288568676},{"date":"2025-10-24","current":-6.425331,"twenty":-11.978881,"median":-9.149542,"eighty":-7.334887,"marketCap":235411289},{"date":"2025-10-31","current":-6.194375,"twenty":-11.800608,"median":-9.102059,"eighty":-7.096882,"marketCap":226949500},{"date":"2025-11-07","current":-5.844979,"twenty":-11.619352,"median":-9.083015,"eighty":-6.739195,"marketCap":214148333},{"date":"2025-11-14","current":-6.453893,"twenty":-11.527382,"median":-8.978494,"eighty":-6.599437,"marketCap":236457733},{"date":"2025-11-21","current":-4.209833,"twenty":-11.386619,"median":-8.807467,"eighty":-6.451943,"marketCap":205321954},{"date":"2025-11-28","current":-4.455369,"twenty":-11.26527,"median":-8.719067,"eighty":-6.366112,"marketCap":217297254},{"date":"2025-12-05","current":-5.535729,"twenty":-11.176245,"median":-8.71121,"eighty":-6.20385,"marketCap":269988572},{"date":"2025-12-12","current":-6.968768,"twenty":-11.12541,"median":-8.663092,"eighty":-6.182531,"marketCap":339880775},{"date":"2025-12-19","current":-6.111623,"twenty":-11.06083,"median":-8.610671,"eighty":-6.174808,"marketCap":298076093},{"date":"2025-12-26","current":-6.366088,"twenty":-10.989171,"median":-8.599121,"eighty":-6.172233,"marketCap":310486858},{"date":"2026-01-02","current":-5.859391,"twenty":-10.980741,"median":-8.405995,"eighty":-6.111623,"marketCap":285774195},{"date":"2026-01-09","current":-6.477696,"twenty":-10.894921,"median":-8.362013,"eighty":-6.093766,"marketCap":315930176},{"date":"2026-01-16","current":-6.852697,"twenty":-10.894921,"median":-8.218152,"eighty":-6.111623,"marketCap":334219725},{"date":"2026-01-23","current":-6.732161,"twenty":-10.894921,"median":-8.171191,"eighty":-6.111623,"marketCap":328340941},{"date":"2026-01-30","current":-5.959837,"twenty":-10.857352,"median":-8.086731,"eighty":-6.108052,"marketCap":290673181},{"date":"2026-02-06","current":-5.040192,"twenty":-10.779084,"median":-8.030062,"eighty":-6.020346,"marketCap":245820240},{"date":"2026-02-13","current":-5.482157,"twenty":-10.700911,"median":-7.926792,"eighty":-5.956266,"marketCap":267375780},{"date":"2026-02-20","current":-5.540193,"twenty":-10.673027,"median":-7.864204,"eighty":-5.92323,"marketCap":270206305},{"date":"2026-02-27","current":-5.580372,"twenty":-10.643124,"median":-7.834638,"eighty":-5.890776,"marketCap":272165900},{"date":"2026-03-06","current":-2.562507,"twenty":-10.619417,"median":-7.684115,"eighty":-5.801764,"marketCap":124978581},{"date":"2026-03-13","current":-2.34822,"twenty":-10.594371,"median":-7.524231,"eighty":-5.747859,"marketCap":114527410},{"date":"2026-03-20","current":-2.187506,"twenty":-10.558368,"median":-7.450451,"eighty":-5.647336,"marketCap":106689032},{"date":"2026-03-27","current":-1.329623,"twenty":-10.505146,"median":-7.272172,"eighty":-5.612515,"marketCap":76574303},{"date":"2026-04-02","current":-1.549332,"twenty":-10.461316,"median":-7.114571,"eighty":-5.565193,"marketCap":89227607},{"date":"2026-04-10","current":-1.477359,"twenty":-10.383939,"median":-7.072594,"eighty":-5.510729,"marketCap":85082559},{"date":"2026-04-17","current":-1.890261,"twenty":-10.268548,"median":-6.92859,"eighty":-5.336927,"marketCap":108862044},{"date":"2026-04-24","current":-2.034209,"twenty":-10.187377,"median":-6.86609,"eighty":-5.089336,"marketCap":117152140},{"date":"2026-05-01","current":-2.056938,"twenty":-10.153251,"median":-6.792493,"eighty":-4.960237,"marketCap":118461102},{"date":"2026-05-08","current":-1.748556,"twenty":-10.125375,"median":-6.716536,"eighty":-4.705593,"marketCap":122169829},{"date":"2026-05-15","current":-2.101422,"twenty":-10.043581,"median":-6.685898,"eighty":-4.518505,"marketCap":146824271},{"date":"2026-05-22","current":-1.408234,"twenty":-9.951007,"median":-6.641483,"eighty":-4.307154,"marketCap":98391896},{"date":"2026-05-29","current":-1.311437,"twenty":-9.918135,"median":-6.60716,"eighty":-4.188404,"marketCap":91628817},{"date":"2026-06-05","current":-1.230253,"twenty":-9.857086,"median":-6.549693,"eighty":-2.633043,"marketCap":85956556},{"date":"2026-06-12","current":-1.136579,"twenty":-9.835549,"median":-6.495974,"eighty":-2.45715,"marketCap":79411641},{"date":"2026-06-18","current":-1.192783,"twenty":-9.824539,"median":-6.468768,"eighty":-2.34822,"marketCap":83338590},{"date":"2026-06-26","current":-1.57997,"twenty":-9.822648,"median":-6.449019,"eighty":-2.187506,"marketCap":110390908},{"date":"2026-07-02","current":-1.754828,"twenty":-9.791341,"median":-6.425331,"eighty":-2.13573,"marketCap":122608083},{"date":"2026-07-10","current":-1.561235,"twenty":-9.726041,"median":-6.368321,"eighty":-2.087243,"marketCap":109081925},{"date":"2026-07-17","current":-1.976523,"twenty":-9.645626,"median":-6.354268,"eighty":-2.066183,"marketCap":138097717},{"date":"2026-07-24","current":-1.995258,"twenty":-9.546006,"median":-6.285834,"eighty":-2.034209,"marketCap":139406700},{"date":"2026-07-31","current":-1.998381,"twenty":-9.523603,"median":-6.216183,"eighty":-2.015866,"marketCap":139624864},{"date":"2026-08-07","current":-2.279403,"twenty":-9.505361,"median":-6.182531,"eighty":-2.029869,"marketCap":159259610},{"date":"2026-08-14","current":-2.007209,"twenty":-9.48453,"median":-6.16129,"eighty":-2.029869,"marketCap":140281862},{"date":"2026-08-21","current":-1.844378,"twenty":-9.46418,"median":-6.116088,"eighty":-2.0169,"marketCap":128901742}],"updateTime":1787456969875},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AARD\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2616175337","title":"Aardvark Therapeutics Shares Fall 54% Premarket After Pausing Late-Stage Rare Disease Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2616175337","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616175337?lang=en_us&edition=fundamental","pubTime":"2026-03-02 21:22","pubTimestamp":1772457725,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nL4N3ZQ1B4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616332459","title":"Stifel Nicolaus Downgrades Aardvark Therapeutics to Hold From Buy, Adjusts PT to $6 From $24","url":"https://stock-news.laohu8.com/highlight/detail?id=2616332459","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616332459?lang=en_us&edition=fundamental","pubTime":"2026-03-02 20:39","pubTimestamp":1772455181,"startTime":"0","endTime":"0","summary":"Stifel Nicolaus Downgrades Aardvark Therapeutics to Hold From Buy, Adjusts PT to $6 From $24","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SF","AARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616331734","title":"Why Is Aardvark Therapeutics Stock Sinking Monday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2616331734","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616331734?lang=en_us&edition=fundamental","pubTime":"2026-03-02 20:02","pubTimestamp":1772452920,"startTime":"0","endTime":"0","summary":"Aardvark Therapeutics Inc.  shares are down during Monday’s premarket session following the company’s announcement to voluntarily pause its Phase 3 HERO trial for Prader-Willi Syndrome.The decision comes as the company is conducting a comprehensive review of safety data.The company on Friday revealed that it will not announce topline data from the HERO trial as previously anticipated in the third quarter of 2026. This pause was prompted by reversible cardiac observations at higher than target therapeutic doses found during routine safety monitoring in a healthy volunteer study.Aardvark’s CEO, Tien Lee, emphasized the commitment to patient safety and the importance of evaluating the signals seen at elevated doses of ARD-101. The company plans to continue collaborating closely with the FDA and the Prader-Willi Syndrome community while determining the next steps for its clinical program.“Assuming resolution of the cardiac safety event, Aardvark may be able to accelerate and streamline the","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/02/Genetic-Research-And-Biotech-Science-Con.jpeg?optimize=medium&dpr=2&auto=webp&width=630","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/02/Genetic-Research-And-Biotech-Science-Con.jpeg?optimize=medium&dpr=2&auto=webp&width=630"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/news/health-care/26/03/50960206/why-is-aardvark-therapeutics-stock-sinking-monday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/03/50960206/why-is-aardvark-therapeutics-stock-sinking-monday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["AARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616904339","title":"Aardvark Therapeutics Inc : Stifel Cuts to Hold From Buy; Cuts Target Price to $6 From $24","url":"https://stock-news.laohu8.com/highlight/detail?id=2616904339","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616904339?lang=en_us&edition=fundamental","pubTime":"2026-03-02 19:58","pubTimestamp":1772452687,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nFWN3ZQ0XU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616315103","title":"RBC Downgrades Aardvark Therapeutics to Sector Perform From Outperform, Cuts Price Target to $6 From $18, Keeps Speculative Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2616315103","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616315103?lang=en_us&edition=fundamental","pubTime":"2026-03-02 19:52","pubTimestamp":1772452323,"startTime":"0","endTime":"0","summary":"Aardvark Therapeutics (AARD) has an average rating of overweight and mean price target of $24.45, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research f","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616366863","title":"Aardvark Therapeutics Cut to Equal-Weight From Overweight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2616366863","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616366863?lang=en_us&edition=fundamental","pubTime":"2026-03-02 19:31","pubTimestamp":1772451060,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AARD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 02, 2026 06:31 ET (11:31 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616335746","title":"Aardvark Therapeutics downgraded to Neutral from Buy at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2616335746","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616335746?lang=en_us&edition=fundamental","pubTime":"2026-03-02 19:15","pubTimestamp":1772450149,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Raghuram Selvaraju downgraded Aardvark Therapeutics (AARD) to Neutral from Buy without a price target The ARD-101 pivotal P...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aardvark-therapeutics-downgraded-to-neutral-from-buy-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aardvark-therapeutics-downgraded-to-neutral-from-buy-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616335183","title":"Aardvark Therapeutics, Inc. : H.c. Wainwright Cuts to Neutral From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2616335183","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616335183?lang=en_us&edition=fundamental","pubTime":"2026-03-02 19:13","pubTimestamp":1772450012,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nAZN4SJ4I9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616333175","title":"Aardvark Therapeutics Cut to Sector Perform From Outperform by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2616333175","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616333175?lang=en_us&edition=fundamental","pubTime":"2026-03-02 18:47","pubTimestamp":1772448420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AARD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 02, 2026 05:47 ET (10:47 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616338410","title":"Stock Market Today: S&P 500, Dow Jones Futures Slide Amid War Against Iran— AMTD Digital, Aardvark, MongoDB In Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2616338410","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616338410?lang=en_us&edition=fundamental","pubTime":"2026-03-02 18:23","pubTimestamp":1772447038,"startTime":"0","endTime":"0","summary":"U.S. stock futures fell sharply on Monday following Friday’s losses. Futures of the major benchmark indices were negative amid the ongoing Iran-U.S. conflict.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/26/03/50958308/stock-market-today-sp-500-dow-jones-futures-slide-amid-war-against-iran-amtd-digital-aardvark-mongodb-in-focus","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2286300806.USD","BK4608","LU1951200564.SGD","VTI","MDBX","IVW","TMF","SPXU","LU1548497426.USD","BK4504","BK4561","VOOV","OEX","BK4161","XDTE","FAZ","OEF","SPXL","LU2357305700.SGD","BK4023","LU2272731782.SGD","LU1861215975.USD","BK4588","LBGJ","LU0154245673.USD","SPYV","BK4526","BK4607","BK4613","MESmain","AARD","LU2272731600.USD","LU0390134368.USD","SH","ALBT","LU1861220033.SGD","SHV","SG9999000418.SGD","HKD","LU1923623000.USD","LU1992135399.USD","SPYI","LU1720051108.HKD","LU1951198990.SGD","SPYM","BK4534","LU0082616367.USD","LU1992135472.HKD","LU0823434740.USD","SPXS","SKRE","IVV","IVOO","SDS","UPRO","BIL","LU0353189680.USD","HIBL","SPDN","BMAY","BK4550","BK4233","LU0353189763.USD","LU0823434583.USD","BK4593","BK4116","LU1720051017.SGD","ESmain","MDB","LU0719512351.SGD","BK4581","SSO","GPIX","BK4205","BK4559","LU2087625088.SGD","BK4585","LU0154245756.USD","SPLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616338469","title":"Aardvark downgraded to Equal Weight from Overweight at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2616338469","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616338469?lang=en_us&edition=fundamental","pubTime":"2026-03-02 18:00","pubTimestamp":1772445625,"startTime":"0","endTime":"0","summary":"Morgan Stanley downgraded Aardvark Therapeutics (AARD) to Equal Weight from Overweight with a price target of $7, down from $29. The emergence of A...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aardvark-downgraded-to-equal-weight-from-overweight-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aardvark-downgraded-to-equal-weight-from-overweight-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0006306889.USD","LU0528227936.USD","LU0225283273.USD","LU0557290698.USD","LU0795875086.SGD","LU0912757837.SGD","BK4504","LU1548497426.USD","LU1989772923.USD","IE00BZ1G4Q59.USD","LU1720051108.HKD","AARD","LU0234570918.USD","LU0106831901.USD","LU1791710582.SGD","LU2347655156.SGD","LU1244550221.USD","LU1732800096.USD","LU2271345857.HKD","LU1074936037.SGD","LU0158827781.USD","LU0267386448.USD","LU2357305700.SGD","LU1989772840.SGD","LU1244550577.SGD","LU2089283258.USD","BK4585","BK4127","LU2111349929.HKD","LU0314104364.USD","LU1720051017.SGD","LU0098860793.USD","LU1363072403.SGD","LU0320765646.SGD","LU0882574139.USD","BK4588","LU0795875169.SGD","LU2133065610.SGD","LU1791710400.SGD","LU0971096721.USD","BK4534","BK4516","LU1244550494.USD","LU1732799900.SGD","LU0158827948.USD","LU2023251221.USD","LU1668664300.SGD","LU2028103732.USD","LU2089284900.SGD","LU1162221912.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616385438","title":"U.S. RESEARCH ROUNDUP-Aardvark Therapeutics, Chevron, CrowdStrike","url":"https://stock-news.laohu8.com/highlight/detail?id=2616385438","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616385438?lang=en_us&edition=fundamental","pubTime":"2026-03-02 15:29","pubTimestamp":1772436556,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Aardvark Therapeutics, Chevron, CrowdStrikeMarch 2 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nL4N3ZQ0J1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AROC","LU2324357040.USD","CPNG","ARES","AVGU","CTVA","CMC","LU1551013342.USD","BURL","AVS","BOBS","AARD","CRWD","AVL","AVGG","BX","CASY","COP","ACLX","AVGO","CVX","DORM","LU2430703251.USD","CBT","ADSK","OWL","ACVA","IRON","BTSG","CAH","APO","CRI","LNG","TCPC","TXG","AES","WHD","ACMR","ARRY","COLD","CRWL","AVGW","CME","COR","ASND","BBWI","AEP","AVGX","AZZ","TGT"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2616580790","title":"Aardvark Therapeutics Inc : RBC Cuts to Sector Perform From Outperform; Cuts Target Price to $6 From $18","url":"https://stock-news.laohu8.com/highlight/detail?id=2616580790","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616580790?lang=en_us&edition=fundamental","pubTime":"2026-03-02 13:50","pubTimestamp":1772430621,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nFWN3ZQ08S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616806325","title":"Aardvark Therapeutics downgraded to Hold from Buy at Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2616806325","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616806325?lang=en_us&edition=fundamental","pubTime":"2026-03-02 10:15","pubTimestamp":1772417705,"startTime":"0","endTime":"0","summary":"Stifel downgraded Aardvark Therapeutics (AARD) to Hold from Buy with a price target of $6, down from $24. The company voluntarily paused its Phase ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aardvark-therapeutics-downgraded-to-hold-from-buy-at-stifel-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aardvark-therapeutics-downgraded-to-hold-from-buy-at-stifel-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AARD","SF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614689344","title":"Stocks to Watch: Aardvark Therapeutics, Blue Moon Metals","url":"https://stock-news.laohu8.com/highlight/detail?id=2614689344","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614689344?lang=en_us&edition=fundamental","pubTime":"2026-02-28 07:38","pubTimestamp":1772235480,"startTime":"0","endTime":"0","summary":"Aardvark Therapeutics is voluntarily pausing a trial after finding safety issues. Shares slumped 54% to $5.75 in after-hours trading Friday.Blue Moon Metals plans to acquire a Utah mine from Teck Resources. Shares rose 5.9% to $5.41 after closing up 17%.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614898320","title":"Aardvark Therapeutics Pauses Trial After Finding Safety Issue","url":"https://stock-news.laohu8.com/highlight/detail?id=2614898320","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614898320?lang=en_us&edition=fundamental","pubTime":"2026-02-28 06:20","pubTimestamp":1772230800,"startTime":"0","endTime":"0","summary":"Aardvark Therapeutics is voluntarily pausing a Phase 3 trial of a drug to treat hyperphagia in patients with Prader-Willi Syndrome.The biopharmaceutical company said it is pausing the trial after finding reversible cardiac observations at above target therapeutic doses in a healthy volunteer study.The company no longer anticipates announcing topline data from the trial with a hunger elimination or reduction objective in the third quarter of 2026, it said. It plans to provide further guidance in the second quarter of this year.Shares tumbled 57%, to $5.45, in after-hours trading Friday. Through the close, the stock was up 25% over the past three months.The trial is for ARD-101, which has demonstrated an ability to reduce hunger when used alone or in combination with currently available GLP-1 therapies. The FDA has granted ARD-101 orphan drug designation and rare pediatric disease designation for Prader-Willi Syndrome.Prader-Willi is a rare genetic disorder which can result in hyperphagi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614260860","title":"BUZZ-Aardvark Therapeutics falls after pausing late-stage rare disease trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2614260860","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614260860?lang=en_us&edition=fundamental","pubTime":"2026-02-28 06:13","pubTimestamp":1772230382,"startTime":"0","endTime":"0","summary":"BUZZ-Aardvark Therapeutics falls after pausing late-stage rare disease trial ** Shares of drug developer Aardvark Therapeutics AARD.O fall 47.2% to $6.58 aftermarkets ** Co says it is voluntarily pausing its late-stage trial testing its experimental treatment for a type of rare genetic disease** Says decision was made after it found heart-related side effects during safety monitoring in a healthy volunteer study in patients receiving higherthanplanned doses of the treatment     ** Says no longer anticipates announcing topline data from the trial in the third quarter of 2026** Stock has fallen 12.6% since its Nasdaq debut last year   ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nL4N3ZN24O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614898854","title":"Aardvark Therapeutics down 54% to $5.70 after pausing Phase 3 HERO trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2614898854","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614898854?lang=en_us&edition=fundamental","pubTime":"2026-02-28 06:00","pubTimestamp":1772229647,"startTime":"0","endTime":"0","summary":"16:57 EST Aardvark Therapeutics (AARD) down 54% to $5.70 after pausing Phase 3 HERO trial Published first on TheFly – the ultimate source for real-...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aardvark-therapeutics-down-54-to-5-70-after-pausing-phase-3-hero-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aardvark-therapeutics-down-54-to-5-70-after-pausing-phase-3-hero-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AARD","HERO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614095862","title":"Aardvark Therapeutics voluntarily pauses Phase 3 HERO trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2614095862","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614095862?lang=en_us&edition=fundamental","pubTime":"2026-02-28 05:11","pubTimestamp":1772226663,"startTime":"0","endTime":"0","summary":"Aardvark Therapeutics (AARD) announced it is voluntarily pausing the Phase 3 Hunger Elimination or Reduction Objective trial. The HERO trial is a P...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aardvark-therapeutics-voluntarily-pauses-phase-3-hero-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aardvark-therapeutics-voluntarily-pauses-phase-3-hero-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HERO","AARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614862431","title":"Aardvark Therapeutics pauses late-stage trial testing rare disease treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2614862431","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614862431?lang=en_us&edition=fundamental","pubTime":"2026-02-28 05:10","pubTimestamp":1772226648,"startTime":"0","endTime":"0","summary":"Aardvark Therapeutics pauses late-stage trial testing rare disease treatment Feb 27  - Aardvark Therapeutics AARD.O on Friday said it is voluntarily pausing its late-stage trial testing its experimental treatment for a type of rare genetic disease.   ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nL4N3ZN20N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AARD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":5,"totalSize":108,"code":"91000000","status":"200"}]}}